P
Payal Gurnani
Researcher at Rush University Medical Center
Publications - 19
Citations - 156
Payal Gurnani is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Medicine & Extracorporeal membrane oxygenation. The author has an hindex of 4, co-authored 14 publications receiving 92 citations. Previous affiliations of Payal Gurnani include Rush Medical College.
Papers
More filters
Journal ArticleDOI
Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department.
Drayton A. Hammond,Payal Gurnani,Alexander H. Flannery,Keaton S. Smetana,Jennifer Westrick,Ishaq Lat,Megan A. Rech,Megan A. Rech +7 more
TL;DR: This scoping review was registered and conducted to identify, aggregate, and qualitatively describe the highest quality evidence for cost avoidance generated by clinical pharmacists on interventions performed in an ICU or ED.
Journal ArticleDOI
Impact of the Implementation of a Sepsis Protocol for the Management of Fluid-Refractory Septic Shock: A Single-Center, Before-and-After Study
Payal Gurnani,Gourang P. Patel,Christopher W. Crank,Dana Vais,Omar Lateef,Sergey Akimov,Robert A. Balk,David Simon +7 more
TL;DR: This study assessed the impact of a sepsis protocol on the timeliness of antibiotic administration, the adequacy of fluid resuscitation, and 28-day mortality in patients with fluid-refractory septic shock.
Journal ArticleDOI
Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
TL;DR: In the treatment of moderate to severe hypercalcemia of malignancy, IV bisphosphonate in combination with calcitonin resulted in a higher difference in corrected calcium levels at 48 hours compared with bisph phosphonate therapy alone.
Journal ArticleDOI
The Clinical Impact of Flow Titration on Epoprostenol Delivery via High Flow Nasal Cannula for ICU Patients with Pulmonary Hypertension or Right Ventricular Dysfunction: A Retrospective Cohort Comparison Study.
TL;DR: In patients with pulmonary hypertension and/or right ventricular dysfunction, trans-nasal iEPO decreased pulmonary arterial pressure and improved oxygenation in patients with combined refractory hypoxemia.
Journal ArticleDOI
Outcomes of Extubated COVID and Non-COVID Patients Receiving Awake Venovenous Extracorporeal Membrane Oxygenation
TL;DR: In this article , the authors evaluated outcomes associated with an awake ECMO strategy in patients with acute respiratory distress syndrome (ARDS) receiving venovenous (VV) extracorporeal membrane oxygenation (ECMO).